Home| Case Studies| Publication Planning

Publication Planning

For our client’s new ultra-long acting insulin for diabetes in Europe and the USA. Develop the strategy for and deliver in 15-months a publication plan supporting the new insulin delivery device.

External experts were identified and engaged as a scientific communications committee for the plan.

A workshop organised within weeks of data availability evaluated the key scientific statements supporting the launch.

ESP created a publication plan integrating the workshop consensus and the launch sequence of USA and then Europe.

With only 6 months to the launch, the launch sequence was switched from the USA to Europe.

ESP reprioritised the delivery of plan activities to aligning with this change.

ESP worked with all stakeholders to ensure delivery of all key plan elements for EU launch. This included successful delivery of over 25 congress communications and peer-reviewed papers in the 2 weeks prior to launch.

This maximised the impact of the plan. The evidence and scientific statements supporting the product were disseminated to the right audiences at the right time.

As such they were available to support all brand communications and activities at launch. Plan assessment metrics demonstrated the plan exceeded all goals set by the client.

  • Our strong working relationship is driven by ESP's positive attitude

    Thank you for the ESP teams excellent work organising the publication steering committee and writing the resulting manuscripts. Our strong working relationship is driven by ESP’s positive attitude, professionalism and ability to deliver to tight deadlines.

  • Thank you for another seamless ESP production

    I would also like to express my gratitude to the team at ESP for a fantastic event. Though the lead up was intense, all the hard work was worth it, as in the end we created a memorable symposium as well as produced a booth that floated high above others efforts! Thank you for another seamless ESP production.

  • ESP Med Comms are my go-to agency!

    Your work is always of the highest quality and demonstrates an excellent understanding of our product and its positioning. Its always a pleasure to work together as you accommodate my rapid requests for urgent work. ESP Medical Communications are my go-to agency!

Read more case studies

Read case study
Read case study
Read case study

Get in touch to discover

how we can help you

Find out more

Meet our management team

Managing Director

A passion for creating communication strategies for clients that change behaviour and improve patients lives made Steve co-found ESP. Steve Waye enjoys working closely with clients to develop innovative approaches and compelling communications to meet their needs.

Steve Waye has worked with ESP clients across numerous therapeutic areas. These include neuroscience, endocrinology, diabetes, medical devices, oncology, haematology, rare diseases cardiovascular disease, rheumatology, gastro-enterology, and HIV. Prior to starting ESP in 2007, Steve led a successful 12-year career in pharmaceutical sales and marketing. Launching brands for cardiology, oncology, haematology and rare diseases. Before going on to hold senior and board positions with global communication agencies.

Read more
Director, Client Services

Catherine Murphy has a passion for people and building exceptional teams who create outstanding work for our clients. She challenges them to go the ‘extra mile’ for clients so they realise the highs of what can be achieved.

Respected by clients for a proven track record of excellent customer service and a creative vision. Catherine Murphy leads multi-disciplinary projects across many therapeutic areas. Her strengths include external expert engagement, meetings management, medical education, training, salesforce effectiveness and benchmarking, and meeting facilitation. Prior to co-founding ESP, Catherine enjoyed a successful 15-year career in senior pharmaceutical sales, learning, and development roles.

Read more
Director, Scientific Services

Recognised by ESP’s clients for his highly developed scientific acumen and therapy area understanding. Martin Gilmour provides scientific oversight and leads the scientific services team in the development of compelling content for communications.

Martin Gilmour's experience includes neuroscience, diabetes, endocrinology, cardiovascular disease, gastroenterology, oncology, haematology, rare diseases, HIV, anti-infectives, anti-fungals, vaccines, and erectile dysfunction. Prior to joining ESP in 2008, Martin spent 12-years with leading communication consultancies in senior medical writing and editorial roles.

Read more